The Validity of a Scoring System in Predicting Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease

被引:1
作者
Nateghian, Alireza [1 ]
Tafreshi, Roya Isa [1 ]
Najari, Arezoo [2 ]
Vaezi, Atefeh [3 ]
机构
[1] Iran Univ Med Sci, Aliasghar Children Hosp, Dept Pediat, Tehran, Iran
[2] Iran Univ Med Sci, Aliasghar Children Hosp, Tehran, Iran
[3] Iran Univ Med Sci, Dept Social Med, Tehran, Iran
来源
ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES | 2016年 / 4卷 / 01期
关键词
Kawasaki Disease; lmmunoglobulins; Intravenous; Treatment Failure;
D O I
10.5812/pedinfect.27527
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Between 10 and 20% of children with Kawasaki disease (KD) will not respond to intravenous immunoglobulin (WIG) treatment, and are prone to coronary abnormalities. A variety of predicting scoring systems, including the Kobayashi system, have been proposed, but have not yet been evaluated using Iranian patients. Objectives: To evaluate the Kobayashi scoring system with regard to predicting response to IVIG treatment in Iranian children. Patients and Methods: All patients who received a final diagnosis of KD at Aliasghar children's hospital between 1982 and 2013, and who met the inclusion criteria, were enrolled in this retrospective cohort study. We excluded patients with missing data, abnormal echocardiographic finding on admission, late admission, atypical or afebrile cases, and those who had received an insufficient amount of IVIG. We compared demographic and echocardiographic data before IVIG, and within 7 days of treatment, as well as C reactive protein (CRP), sodium, aspartate aminotransferase, platelet levels, neutrophil percentage, age of patients, and duration of fever before WIG administration, in treatment responders and non-responders. Results: Of the 141 cases, 97 patients met the criteria and were enrolled. Of these, 19 (19.6%) did not respond to WIG. A total of 61.8% of patients were male, and the mean patient age was 36.9 months (SD = 32.1 months). Echocardiographic evaluation revealed early coronary involvement in 15.3% of patients, and coronary abnormalities were diagnosed in 10% of patients within the firstio days of presentation and concurrent with their IVIG treatment. A between-groups comparison of quantitative CRP, absolute neutrophil count, and platelet count showed that platelet count alone was significantly higher in nonresponders (P = 0.04). With regard to items of Kobayashi scoring system, data were present for just 41 cases, but a significant difference between the two groups was shown, with the treatment-refractory group having a significantly higher score (P= 0.002). Receiver-operating characteristic curve analysis revealed that the optimum cut-off point for our population would be 2, which makes the sensitivity of the test equal to 75%, with a specificity of 60%. Conclusions: This preliminary study showed that patients with KD and a high Kobayashi score are at greater risk of being unresponsive to IVIG treatment. Further studies, preferably multicenter evaluations, are required in order to understand the exact application of various scoring systems in the management of people with KD in Iran.
引用
收藏
页数:5
相关论文
共 17 条
  • [1] Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)
    Ayusawa, M
    Sonobe, T
    Uemura, S
    Ogawa, S
    Nakamura, Y
    Kiyosawa, N
    Ishii, M
    Harada, K
    [J]. PEDIATRICS INTERNATIONAL, 2005, 47 (02) : 232 - 234
  • [2] Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease
    Cha, Sungho
    Yoon, Minjeong
    Ahn, Yongjoo
    Han, Miyoung
    Yoon, Kyung-Lim
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 718 - 722
  • [3] Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
    Egami, Kimiyasu
    Muta, Hiromi
    Ishii, Masahiro
    Suda, Kenji
    Sugahara, Yoko
    Iemura, Motofumi
    Matsuishi, Toyojiro
    [J]. JOURNAL OF PEDIATRICS, 2006, 149 (02) : 237 - 240
  • [4] Management of Kawasaki disease
    Eleftheriou, D.
    Levin, M.
    Shingadia, D.
    Tulloh, R.
    Klein, N. J.
    Brogan, P. A.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (01) : 74 - 83
  • [5] Karimi A, 2002, SCI J HAMEDAN U MED, V9, P17
  • [6] Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
    Kobayashi, Tohru
    Inoue, Yoshinari
    Takeuchi, Kazuo
    Okada, Yasunori
    Tamura, Kazushi
    Tomomasa, Takeshi
    Kobayashi, Tomio
    Morikawa, Akihiro
    [J]. CIRCULATION, 2006, 113 (22) : 2606 - 2612
  • [7] Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
    Lee, Sang Min
    Lee, Jeong Bong
    Go, Young Bin
    Song, Ho Young
    Lee, Byung Jin
    Kwak, Ji Hee
    [J]. KOREAN CIRCULATION JOURNAL, 2014, 44 (06) : 415 - 422
  • [8] Epidemiology of Immunoglobulin Resistant Kawasaki Disease: Results from a Large, National Database
    Moffett, Brady S.
    Syblik, Dorothy
    Denfield, Susan
    Altman, Carolyn
    Tejtel-Sexson, Kristin
    [J]. PEDIATRIC CARDIOLOGY, 2015, 36 (02) : 374 - 378
  • [9] Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome
    Rigante, Donato
    Valentini, Piero
    Rizzo, Daniela
    Leo, Andrea
    De Rosa, Gabriella
    Onesimo, Roberta
    De Nisco, Alessia
    Angelone, Donatella Francesca
    Compagnone, Adele
    Delogu, Angelica Bibiana
    [J]. RHEUMATOLOGY INTERNATIONAL, 2010, 30 (06) : 841 - 846
  • [10] Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
    Sano, Tetsuya
    Kurotobi, Shunji
    Matsuzaki, Kouji
    Yamamoto, Takehisa
    Maki, Ichiro
    Miki, Kazunori
    Kogaki, Shigetoyo
    Hara, Junichi
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (02) : 131 - 137